
Hermetica Superfood Encyclopedia
Crimson Cinnamon Bark (Cinnamomum osmophloeum) is a Taiwanese endemic tree whose bark essential oil contains 62–77% trans-cinnamaldehyde, a bioactive aldehyde demonstrated in preclinical models to activate AMP-activated protein kinase (AMPK) signaling, enhance GLUT4-mediated glucose uptake, and exert potent anti-inflammatory and antimicrobial effects. Although no human clinical trials specific to C. osmophloeum bark have been indexed in PubMed to date, phytochemical analyses published in the Journal of Agricultural and Food Chemistry and reviews in Evidence-Based Complementary and Alternative Medicine confirm its rich cinnamaldehyde profile and broad-spectrum bioactivity comparable to Cinnamomum verum and C. cassia.

Health Benefits
Origin & History

Crimson Cinnamon Bark (Cinnamomum spp.) is derived from trees native to tropical rainforests and highland regions of Southeast Asia, the Indian subcontinent, and Central America. It is prized for its aromatic bark and its historical use in metabolic regulation and cardiovascular support.
Scientific Research
Phytochemical characterization studies published in the Journal of Agricultural and Food Chemistry have confirmed that Cinnamomum osmophloeum bark essential oil is dominated by trans-cinnamaldehyde at 62–77% of total volatiles, positioning it among the most cinnamaldehyde-rich Cinnamomum species. A comprehensive review in Evidence-Based Complementary and Alternative Medicine (2014) evaluated antioxidant, anti-inflammatory, antidiabetic, and antimicrobial activities of multiple Cinnamomum species including C. osmophloeum, noting significant free-radical scavenging and NF-κB pathway inhibition in vitro. A widely cited multifaceted review by Rao and Gan (2014) in BMC Complementary and Alternative Medicine (PMC4003790) catalogued the pharmacological activities of cinnamon-derived cinnamaldehyde, including insulin-mimetic effects and lipid-lowering properties across rodent models. No human randomized controlled trials specific to C. osmophloeum bark have yet been indexed in PubMed, underscoring the need for translational clinical research.
Preparation & Dosage

Nutritional Profile
- Phytochemicals: Polyphenols (cinnamaldehyde, eugenol, catechins), Flavonoids (quercetin, kaempferol, myricetin), Volatile oils (cinnamate, benzyl benzoate, safrole), Coumarins. - Fiber: Soluble and insoluble fiber. - Vitamins: Vitamin K. - Minerals: Manganese, iron.
How It Works
Trans-cinnamaldehyde (62–77% of bark oil) activates AMP-activated protein kinase (AMPK), a master cellular energy sensor, which in turn phosphorylates acetyl-CoA carboxylase (ACC), suppressing de novo lipogenesis and promoting fatty acid oxidation in hepatocytes. AMPK activation simultaneously stimulates translocation of glucose transporter type 4 (GLUT4) to the plasma membrane of skeletal muscle and adipose cells, enhancing insulin-independent glucose uptake and improving glycemic control. The compound also inhibits nuclear factor kappa-B (NF-κB) signaling by blocking IκB kinase (IKK) phosphorylation, thereby reducing expression of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Additionally, cinnamaldehyde modulates Nrf2/ARE antioxidant response pathways, upregulating endogenous antioxidant enzymes such as superoxide dismutase (SOD), catalase, and heme oxygenase-1 (HO-1), which collectively attenuate oxidative stress.
Clinical Evidence
Current evidence for Crimson Cinnamon Bark relies primarily on preclinical in vitro and animal studies rather than human clinical trials. Research demonstrates that trans-cinnamaldehyde and CB403 (synthesized from bark compounds) inhibit tumor cell growth in laboratory cultures and animal models. While general cinnamon bark studies show metabolic and cardiovascular benefits in humans, specific quantified clinical outcomes for C. osmophloeum bark are lacking. Further randomized controlled trials with defined dosages and measured endpoints are needed to establish clinical efficacy.
Safety & Interactions
Cinnamomum osmophloeum bark, like other cinnamaldehyde-rich cinnamon species, may potentiate the hypoglycemic effects of antidiabetic medications (e.g., metformin, sulfonylureas, insulin) and should be used cautiously in individuals on blood sugar–lowering therapy to avoid additive hypoglycemia. Trans-cinnamaldehyde has been shown in vitro to inhibit cytochrome P450 enzymes CYP2A6 and CYP2E1, which could theoretically alter the metabolism of drugs processed through these pathways, though clinical significance in humans remains unestablished. Unlike Cinnamomum cassia, C. osmophloeum bark reportedly contains negligible coumarin levels, reducing the hepatotoxicity risk associated with high-dose cassia consumption; however, individuals with liver disease should still exercise caution. Pregnant and breastfeeding women should consult a healthcare provider before supplementing, as high-dose cinnamaldehyde has demonstrated uterotonic activity in animal models.
Synergy Stack
Also Known As
Frequently Asked Questions
What are the health benefits of crimson cinnamon bark?
How is crimson cinnamon bark different from regular cinnamon?
Can crimson cinnamon bark help lower blood sugar levels?
Is crimson cinnamon bark safe to take with diabetes medication?
What is the recommended dosage of crimson cinnamon bark?
Is crimson cinnamon bark safe during pregnancy and breastfeeding?
Does crimson cinnamon bark interact with blood thinners or anticoagulant medications?
What is the most bioavailable form of crimson cinnamon bark supplement?
Conditions This May Help
This profile shares topic or mechanism tags with the health areas below. The links open provisional public-profile indexes; association does not establish a benefit or clinical recommendation.
Or jump to the curated Inflammation & Joint Health Profile Collection → a provisional discovery list with review-state disclosure.
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.














